Using intact, beating hearts, we have assessed the interaction of insulin with capillary endothelium and the subsequent appearance of insulin in cardiac muscle. Rat hearts were perfused with '25I-insulin (10`0 M) alone or in combination with unlabeled insulin (10-9-10-5 M). 125I grains (shown to represent > 90% intact insulin) over both capillary endothelium and cardiac muscle decreased in a dose-dependent manner when hearts were co-perfused with labeled insulin and increasing concentrations of unlabeled insulin. Perfusion of 125I-desoctapeptide (DOP) insulin, a low affinity insulin analogue, with unlabeled insulin (10-9-10-5 M) had no effect on the appearance of 125I-DOP insulin over microvessel endothelium and muscle. When capillary receptors were first destroyed by trypsin treatment or blocked by anti-receptor antibodies, the appearance of 125I-insulin in cardiac muscle decreased proportional to the inhibition of insulin binding to the capillary receptors. We conclude that insulin binding to capillary endothelial receptors is a central step in the transport of intravascular insulin to rat cardiac muscle.
Introduction
Specific binding sites for insulin are present on the surface of endothelial cells derived from both microvessels and macrovessels (1) (2) (3) (4) (5) (6) (7) . In certain endothelium, such as capillary endothelial cells, these receptors initiate insulin-stimulated cellular functions that include thymidine incorporation into DNA, glucose conversion to glycogen, and cellular transport of glucose and amino acids (3, 8, 9) . In addition to initiating cellular effects of insulin, the endothelial receptors for insulin may function in the transendothelial transport ofbiologically intact insulin. When cultured endothelial cells are exposed to insulin, the hormone binds to its cellular surface receptor, is transferred to an intracellular compartment(s), and is then rapidly released from the cell as intact insulin in a manner consistent with transendothelial transport of the hormone (10) (11) (12) (13) . Such processing of insulin has been documented for endothelial cells cultured from several large-caliber, conducting blood vessels as well as from capillaries.
In the present study, the perfused Langendorff beating heart preparation has been utilized to determine the role of receptor-mediated insulin transfer from the capillary circulaReceived for publication 27 December 1985 and in revised form 11 August 1987.
tion to the subjacent cardiac muscle. The perfused heart preparation has several properties that make it particularly appropriate for such studies. First, we have previously demonstrated that capillary endothelial cells of the beating heart have specific receptors for insulin, as determined by both kinetic and morphometric analysis (7) . Second, the perfused heart retains several insulin-mediated functions of cardiac muscle, including stimulation of glucose uptake and lactate production (14) (15) (16) . Finally, the interendothelial junctions of the heart capillaries are of the "tight" or occluding type. In other capillary beds characterized by similar occluding junctions, neutral molecules the size of insulin cross the endothelium by mechanisms other than diffusion between the cells ( 17) .
Methods
Preparation of12sI-A,4-insulin and 125S1desoctapeptide
(DOP)' insulin '25I-A14-insulin was prepared by the method of Lioubin et al. (18) .
Briefly, insulin (Eli Lilly & Co., Indianapolis, IN) was iodinated by the lactoperoxidase method and the labeled peptides were applied to a C-18 Porasil precolumn, washed with buffer to eliminate the free 125I-iodide, and placed "in line" with a C-18 HPLC column. The monoiodinated '25I-A14-insulin was eluted isocratically with 29% acetonitrile. Specific activity of the '251I-A14-insulin was -300 ,Ci/,ug insulin. '251-DOP insulin was prepared by stepwise chloramine T oxidation. The 1251-DOP insulin was applied to a Sephadex G-50-40 column (Sigma Chemical Co., St. Louis, MO), with the radioactive peak comigrating with authentic '251-A14-insulin collected, and the midportion of this peak used for experiments. Specific activities of the '25I-DOP insulin ranged from 100 to 150 ,Ci/ug DOP insulin. The precipitability of '251I-DOP insulin in 5% TCA was determined before each experiment and ranged from 92 to 98%. The unlabeled DOP was -0.1% as potent as porcine insulin in competing with '25I-porcine insulin for insulin receptors on cultured endothelial cells (data not shown). DOP insulin was a kind gift of Dr. Ronald Chance (Eli Lilly & Co.).
Heart perfusion andfixation
Rats (CD strain, male, 300 g, Charles River Breeding Laboratory, Wilmington, MA) were anesthetized with methoxyflurane (PitmanMoore, Inc., Washington Crossing, NJ), the chest cavities opened, and the hearts removed and suspended by a perfusion catheter placed in the aorta (7) . The isolated heart was perfused in retrograde fashion with perfusate flowing from aorta to coronary arteries to the microvessels, and finally collected via a slit made in the right ventricle. The buffer solution, to which all hormones and other agents were added, consisted of Hanks' balanced salts (pH 7.4) buffered with 15 mM Hepes (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) in place of sodium bicarbonate and containing glucose (I g/liter) and fatty acid-poor albumin (I mg/ml). Oxygenated buffer and insulin-containing solutions (pH 7.4, 37°C) were perfused using peristaltic pumps at sufficient rate and pressure to close the aortic valve leaflets and maintain the ventricular heart rate at 50-90 beats/minute. Trypsin and anti-insulin receptor antibody studies Trypsin. Hearts were perfused with several concentrations of trypsin (Difco Laboratories, Inc., Detroit, MI) ranging from 1 to 0.05% for 1 min, followed by perfusion with buffer for 30 s. The hearts were then perfused with '25I-insulin ( 10`0 M) alone or 1251-insulin plus unlabeled insulin at 10-M and processed for radioautography as previously described. Several sections of myocardium were prepared from each trypsin-treated heart for assessment of morphologic integrity by electron microscopic evaluation. Perfusion with trypsin at 0.2% or less did not alter the heart beat rate; perfusion at 1% trypsin caused slowing of heart rate, which was reversed with subsequent perfusion with buffer alone.
Anti-receptor antibodies. Serum containing anti-insulin receptor antibodies from patient B-7 was used for these studies ( 19) . The effect of serum B-7 on insulin binding to cultured cells was assessed in microvessel endothelial cells cultured from bovine adipose tissue (9) and studied after one passage in vitro. Monolayer cells in 6-well trays were incubated at 22°C for 1 h with serum B-7 at dilutions of 1:50 and 1:250, the cells washed and assayed for insulin binding using '25I-A14-insulin as previously described (9) .
For heart perfusions, serum B-7 was co-perfused at each of two graphed using a Hitachi H600 electron microscope, and negatives printed at 16,000 to 20,000 times final magnification. Areas of muscle were computed by a Zeiss MOPP digitizer and the gold particles quantitated. Second, serum from patient B-7 and control serum were precipitated with ammonium sulfate (33% final concentration), the precipitate redissolved in phosphate buffer (0.01 M KH2PO4, pH 8), and dialyzed for 24 h in phosphate buffer, using dialysis tubing with a 3,500 D cutoff range. The retained material was concentrated and iodinated with 1251I using chloramine T oxidation to a final specific activity of 10-15 ,Ci/Mg protein as previously described by Jarrett et al. (21) . Additionally, the ammonium sulfate precipitates were further resolved on DEAE ion exchange chromatography according to the procedure of Jarrett et al. (21) . The DEAE-purified material was also concentrated, iodinated with '25I to a specific activity of - [10] [11] [12] [13] [14] [15] ,MCi/Mg protein. The iodinated material from the ammonium sulfate precipitation and the DEAE columns then were each used in heart perfusions as previously described for '251-insulin perfusion. Serum B-7 was a generous gift of Dr. P. Gorden (National Institutes of Health, Bethesda, MD).
Results

Nature of125I grains over capillaries and cardiac muscle
Before analyzing the radioautographic data of the perfused heart, the chemical nature ofthe 1251I grains over capillaries and muscle was first determined in hearts that had been perfused with '25I-insulin. In similar heart perfusion experiments with '251I-insulin, we have previously demonstrated that the radioac- tivity associated with capillaries represents intact '251I-insulin (7) . To characterize the muscle radioactivity, 1251-insulin was perfused through the heart for 2 min and the '25I-insulin removed from the vascular system by rapid perfusion with excess cold insulin and then trypsin (1%, 30 s). In such preparations, the remaining radioactivity was shown to overlay cardiac muscle by autoradiographic examination. After trypsin treatment, the hearts were minced and sonicated in the presence of 0.1% Triton X-100 and several protease inhibitors (10 mM N-ethylmaleimide, 0.92 mM phenylmethylsulfonyl fluoride, and 1 mM bacitracin). The Heart perfusions with '25I-insulin '251I-Insulin (10-10 M) was perfused through the beating hearts for 2 min by itself or with varying concentrations of unlabeled insulin. The tissues were then fixed and subsequently analyzed for radioautographic grain counts over capillaries and cardiac muscle (Fig. 2 A) . Grain counts over both capillaries and muscle were maximal when '251-insulin was perfused alone and decreased progressively in both capillary and muscle compartments as increasing concentrations of unlabeled insulin were co-perfused with the '251I-insulin (Fig. 3) . Unlabeled insulin at 
I25-DOP insulin
Characterization. The binding properties of the 251I-DOP insulin were first evaluated in both cultured microvessel endothelial cells and cultured IM-9 lymphoblastoid cells, two cell types with well-characterized receptors for insulin (Fig. 4 ).
Competition studies with '251I-DOP insulin and varying con- . Cell-bound radioactivity in endothelial cells was separated from free radioactivity by washing the monolayer times three and dissolving the cells in 0.1 N NaOH as previously described (9) . Cell-bound radioactivity in IM-9 cells was determined by centrifugation. Nonspecific binding was 10%, and degradation of labeled hormone -3% for both cell types. (Fig. 4, left) , while in the IM-9 cells, maximal binding of 1251-insulin was 12 vs. 1.2% for 12511 DOP insulin (Fig. 4, right) . Heart perfusion. Heart perfusions similar to those described for '251-insulin were performed using '251I-DOP insulin (Fig. 5) . To facilitate comparison with the '251I-insulin studies, similar numbers of counts of '251I-DOP insulin were perfused for identical time periods (2 min). Two major differences are apparent when'251I-DOP insulin is used as the labeled ligand (Fig. 5, dashed (Fig. 6 B) . In contrast, at the lower concentrations of trypsin (0.2 and 0.05%), detailed electron microscopy analysis demonstrated normal capillary endothelial morphology (Fig. 6, C and D) . No obvious morphological alterations were detected in the muscle compartment at any trypsin concentration. Fig. 7 (Fig. 7) .
Autoradiographic analysis of themuscle compartments of hearts treated with 1 and 0.2% trypsin demonstrated different results. With 1% trypsin treatment, muscle counts were increased to 160% of control despite the marked decrease in capillary binding in the same hearts. When considered in the context of the morphologic findings of endothelial cell disruption with 1% trypsin, the data with 1% trypsin are most consistent with major transendothelial leaks induced by the trypsin treatment. The observation that unlabeled insulin did not compete for the majority of1251 grains in the muscle compartment could reflect "nonspecific" trapping of125I-insulin or possible degradation of'25I-insulin and deposition of 125I degradation products in the muscle compartment. The 0.2% trypsin-treated hearts showed decreased '25I grains in the muscle compartment (32% less than control) that were approximately proportional to the decrease in grain density observed at the capillary endothelial sites for insulin binding. Finally, perfusion of hearts with the lower trypsin concentration, 0.05%, resulted in no effect on grain counts over capillaries or muscle.
Hearts that were preperfused with trypsin at 0.2% were also analyzed for the nature of 125I after the 2-min perfusion with '25I-insulin, and found to be similar to hearts that were perfused with buffer only (Fig. 1), i.e., > 90% of 1251 remained in the form of intact '25I-insulin.
Anti-insulin receptor antibodies. Serum obtained from patient B-7 was used in these studies (19) . This patient had a severe form of insulin resistance caused by the presence of anti-insulin receptor antibodies in her circulation. Her serum, referred to as serum B-7, contained anti-insulin receptor antibodies predominantly of the IgG class. In the present studies serum B-7, at dilutions of 1:50 and 1:250, was co-perfused through hearts with '251-insulin(10-' 0 M) for periods of 30, 60, and 120 s, and the hearts then analyzed autoradiographically for 1251I grains in the capillary and muscle compartments (Fig. 2  B and Fig. 8) . At a 1:50 dilution, serum B-7 inhibited insulin binding to capillaries with capillary-bound'25I-insulin being 45, 68, and 85% less than control after 30, 60, and 120 s of perfusion, respectively (Fig. 8, left) (Fig. 2 C) . With both gold labels, -99% of gold particles were found in the capillary compartment, a few gold particles were found in interstitial spaces, and only an occasional gold particle was located in the muscle compartment (Table I) . Second, Ig-enriched fractions of sera obtained by both 33% ammonium sulfate precipitation and DEAE ion exchange chromatography of serum B-7 and control serum were prepared and iodinated with 1251I at _ 10-15 uCi/,ug protein.
Because limited transfer of Ig was anticipated, the labeled Igs were perfused through the hearts at significantly higher counts per minute than was used in studies with 1251-insulin perfusion.
Labeled Ig preparations of control serum, both 33% ammonium sulfate precipitates of B-7 serum, and DEAE ion exchange chromatography of B-7 serum corresponding to a 1:50 dilution of serum (-60 X 106 cpm/ml) were perfused for 30 s, and '251-Ig preparations corresponding to a 1:250 serum dilu- tion (-12 X 106 cpm/ml) were perfused for 90 s, then prepared for radioautography. Autoradiographs were developed for identical periods as hearts exposed to '25I-insulin only (-2 X 106 cpm '251-insulin/ml). For the 1251I-labeled serum preparations (control and B-7), -99% of grains were localized to capillaries with < 1% of grains in the muscle compartment (Table I) 
Discussion
We have utilized a functioning, intact heart perfusion system to assess the role of capillary endothelial cell receptors for insulin in the transfer of the hormone to its major subendo- One alternative explanation for these findings is related to possible effects of insulin on capillary endothelial permeability (22) . The unlabeled insulin could have had a generalized effect on endothelial cell permeability to all proteins independent of the proteins' ability to bind to capillary endothelial receptors. To test this possibility, studies were repeated using '25I-DOP insulin. The '25I-DOP insulin was similar to '25I-insulin in size, structure, and charge, but had little affinity for insulin receptors, therefore making it an appropriate probe to assess insulin receptor specificity. In studies with '251I-DOP insulin, unlabeled insulin, at concentrations of up to 10-5 M, had no effect on 1251I-DOP insulin binding to capillaries or its appearance over cardiac muscle. Therefore, it is unlikely that the unlabeled insulin caused a decrease in muscle '251I-insulin by nonspecifically affecting the permeability properties of the capillary endothelium.
A second possible explanation for the findings of the present study would postulate a rapid, nonreceptor-mediated capillary uptake of insulin. In this respect, the data in Fig. 3 would simply reflect competition of labeled and unlabeled insulin for two distinct populations of insulin receptors, i.e., one group of receptors in capillary endothelium and the second in cardiac muscle. The data from experiments with trypsin and anti-insulin receptor antibodies argue against this explanation. When capillary insulin binding sites were destroyed by trypsin concentrations that did not grossly affect microvessel integrity (0.2% trypsin), or when capillary receptors were blocked by anti-receptor antibodies, there was a decreased appearance of insulin in cardiac muscle. In both the trypsin and antireceptor studies, the degree of impaired insulin delivery to muscle was roughly proportional to the loss of capillary binding sites for insulin, suggesting a major role of the capillary receptors in the transfer of insulin from the vascular compartment to cardiac muscle. For the anti-receptor antibody studies, these findings occurred when an insignificant amount, if any, antibody had left the vascular compartment, ruling out a competitive effect of the antibodies at the level of cardiac muscle receptors for insulin. Thus, taken together, the data of the present study suggest that the capillary endothelial receptors for insulin have a central role in the transport of the majority of intact insulin that moved from the intravascular compartment to cardiac muscle. Furthermore, the proportionality between insulin binding to capillary receptors and the appearance of insulin in cardiac muscle suggests that the binding of insulin to the endothelial cell surface and not subsequent intraendothelial processing is normally the rate-limiting step in the transport of insulin to cardiac muscle.
Our findings have many potential physiologic and pathologic implications. At a minimum, they indicate an additional control point for the tissue action of insulin, namely the capillary endothelium. Alteration in endothelial function is already considered a characteristic finding in such disease processes as diabetes mellitus, a pathologic condition characterized by abnormalities of both the secretion of insulin and insulin action. In diabetes, retinal capillary beds demonstrate interendothelial leakage of small proteins, increased transcapillary exchange of plasma fluid components, and endothelial cell proliferation, with each of these findings preceding clinically detectable lesions of the retinal microvasculature (23, 24) . Our data in the present study now suggest that certain capillary endothelia also serve to control the transcapillary movement of insulin, the hormone central to normal glucose homeostasis. With the attendant abnormalities of capillary endothelial function already described in diabetes, coupled with the thickened endothelial basement membrane that accompanies the disease, it is plausible that tissue levels of insulin are altered not only by diminished circulating levels of insulin but also by defective endothelial transfer of the hormone to the tissue.
The precise pathway required for the transendothelial movement of insulin, as well as other small molecular weight polypeptides, is uncertain. The data of the present study have been obtained in the rat heart, which contains capillary endothelia that are dominated by occluding intercellular junctions and a high degree of micropinocytotic vesiculation (17) . In studies of analogous muscular capillaries with vesiculated endothelia having occluding interendothelial junctions, proteins as small as 1,550 D appear to pass through the capillary endothelial cell without permeating interendothelial cell junctions (25) . Until recently, most authors agreed that the highly developed plasmalemmal vesicle system of these endothelia served as the transendothelial carriers of the small proteins, with vesicles pinching off at the lumenal or ablumenal surface, migrating across the cell, and finally discharging their contents at the opposite pole of the cell, a process designated transcytosis (25) . More recent ultrastructural study of capillary endothelial cells have questioned the interpretation of the vesicular system as a discrete shuttle system. Both Bungaard (26) and Frokjaer-Jensen (27) have prepared three-dimensional reconstructions of endothelial segments from frog mesenteric capillaries and rat heart capillaries based on ultrathin serial sectioning. These authors have shown that the intraendothelial free vesicles observed on random thin sections are not true vesicles but parts of an elaborate caveolar system of interconnected invaginations of the lumenal and ablumenal surfaces. They suggest that such a static ultrastructural system is not compatible with active formation of discrete vesicles acting as transendothelial carriers. Thus, while the plasmalemmal vesicular system is thought to be critical for transendothelial passage of small proteins in capillaries such as those perfusing the myocardium, the details of such vesicular passage have not been elucidated.
In this regard, it is relevant to consider that not all capillary endothelium have occluding intercellular junctions, and that several capillary networks, particularly those of the central nervous system, may have occluding-type intercellular junctions but normally exhibit few intracellular endothelial vesicles (28) . However, these capillary endothelial cells of the central nervous system can be induced to develop intracellular vesiculated structures in pathological conditions such as hypertension (29) . Whether such diversity of endothelial morphology, coupled with differential surface affinities for the insulin molecule, would be factors controlling capillary transport of the hormone remain to be determined for each microvessel bed.
